Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Sergioo
    Member
    • Oct 2013
    • 29

    Region of zero coverage

    Dear all,
    I have been sequencing some samples and found something that is new for me.
    After sequencing using Miseq, I usually align reads using CLC Genomic Workbench and from there, I get the visual of the mapping in general before proceeding to any downstream analysis.
    Now, I've got some area of zero coverage and immediately though of sequencing errors. The problem is that this "hypothetical" error is seen in all my samples at a particular gene that is not seen by PCR in 1/2 of my samples (so it was reported as missing in PCR experimental data for those samples).
    So, finally this let me think about just a kind of large deletion in the gene that has caused a significant change (for it not to be amplified by PCR) and altered presumably the function of of it. Does it make sense?
    I think a gene may not be amplified in PCR for a number of reasons (no need to list them here), and obviously, sanger sequencing can not help. But for NGS, what should we expect? Please help brainstorming about this and see if I can come up with a new idea from the forum.
    Please see attached the visualization of the mapping at that region (2 samples).
    Thanks all,
    Last edited by Sergioo; 03-31-2014, 10:52 PM. Reason: No answer despite over 100 visits
  • TiborNagy
    Senior Member
    • Mar 2010
    • 329

    #2
    Yes, it can be a deletion.

    Comment

    • Sergioo
      Member
      • Oct 2013
      • 29

      #3
      Originally posted by TiborNagy View Post
      Yes, it can be a deletion.
      Thanks for your reply, but how do we know if it is a deletion or poor assembly/mapping ?

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        How big is this "deletion"? Are you seeing sharp edges at the boundaries where the reads stop being mapped to reference? Do these reads have parts that are left over?

        You talked about attaching an image but I do not see it with your first post. Can you post that?

        Comment

        • Sergioo
          Member
          • Oct 2013
          • 29

          #5
          Originally posted by GenoMax View Post
          How big is this "deletion"? Are you seeing sharp edges at the boundaries where the reads stop being mapped to reference? Do these reads have parts that are left over?

          You talked about attaching an image but I do not see it with your first post. Can you post that?
          Thanks for your reply, Please see attached Pic 1 & 2., the deletion covers ~100,000 bp (The genome is ~3000 Mb) but in different area/regions. Please note that some regions correspond to genes that were not amplified using PCR (in a previous experiment) and thus the gene were considered missing.
          Regards,
          Attached Files

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            Originally posted by Sergioo View Post
            Please note that some regions correspond to genes that were not amplified using PCR (in a previous experiment) and thus the gene were considered missing.
            Regards,
            At least for these regions the NGS data should be additional evidence that they are indeed missing. (note: The thumbnails are hard to see so it is not clear if there are NO reads covering the deleted region).

            Since these regions can be treated as positive controls for the rest of the data perhaps the other regions identified by NGS data are also missing (a hypothesis that would have to be proved by using PCR or something else).

            Comment

            • Brian Bushnell
              Super Moderator
              • Jan 2014
              • 2709

              #7
              Originally posted by Sergioo View Post
              Thanks for your reply, but how do we know if it is a deletion or poor assembly/mapping ?
              If you are interested in finding large deletions with mapping, I highly recommend you try BBMap. For a 3GB organism the command line would be like this:

              (index)
              bbmap.sh -Xmx24g ref=reference.fasta

              (map)
              bbmap.sh -Xmx24g in=reads.fq out=mapped.sam bs=bs.sh maxindel=200000 ambig=random

              The "bs" flag is optional; it stands for "bamscript" and will tell BBMap to write a shellscript that, when executed, will use samtools to create a sorted indexed bam file which is needed by visualization programs like IGV.

              Anyway, that command line will map and look for deletions of up to 200kbp. They will be contained within the reads' cigar strings (e.g. 40M100000D60M), so there will be no ambiguity about whether there is a deletion, or simply an area that happens to have no coverage.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                Yesterday, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 11:10 AM
              0 responses
              9 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              30 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              40 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              25 views
              0 reactions
              Last Post SEQadmin2  
              Working...